Jh. Krystal et al., SPECIFICITY OF ETHANOLLIKE EFFECTS ELICITED BY SEROTONERGIC AND NORADRENERGIC MECHANISMS, Archives of general psychiatry, 51(11), 1994, pp. 898-911
Background: This study evaluated the specificity of the ethanollike ef
fects of the serotonergic receptor partial agonistm-chlorophenylpipera
zine hydrochloride (MCPP) relative to the alpha(2)-adrenergic receptor
antagonist yohimbine hydrochloride and the placebo in recently detoxi
fied alcoholics. It also examined the relationship between ethanollike
discriminative properties and the induction of craving in these patie
nts. Both MCPP and yohimbine are anxiogenic in humans; thus, this stud
y evaluated the role of anxiogenic and ethanollike effects in the elic
itation of craving. Methods: Twenty-two male inpatients who met DSM-II
I-R criteria for alcohol dependence and who had not consumed alcohol f
or 12 to 26 days prior to the study completed 3 days of testing that i
nvolved the intravenous infusion of MCPP (0.1 mg/kg), yohimbine hydroc
hloride (0.4 mg/kg), or a saline solution over 2 weeks under double-bl
ind conditions. Ethanollike subjective effects were assessed using the
Sensation Scale and visual analog scales to measure the degree of sim
ilarity to the effects of ethanol, cocaine, and marijuana. Five compon
ents of craving for alcohol were assessed using visual analog scales.
The effects of the drugs on mood were assessed using visual analog sca
les. Plasma levels of cortisol, prolactin, and 3-methoxy-4-hydroxyphen
yl-ethyleneglycol were also measured during the test days. Results: m-
Chlorophenylpiperazine and yohimbine produced significant increases co
mpared with placebo in Sensation Scale scores and the visual analog sc
ale score for nervousness. However, the effects of MCPP were rated as
more similar to those of ethanol, cocaine, and marijuana than were tho
se of either yohimbine or placebo. Also, MCPP but not yohimbine or pla
cebo significantly increased craving for alcohol. Yohimbine and MCPP i
ncreased plasma prolactin and cortisol levels relative to placebo, whe
reas only yohimbine increased plasma 3-methoxy-4-hydroxyphenylethylene
glycol levels. Conclusions: m-Chlorophenylpiperazine produced ethanoll
ike effects and alcohol craving in recently detoxified alcoholics. Yoh
imbine increased Sensation Scale scores but was not recognized as etha
nollike by patients. Although both drugs produced comparable levels of
nervousness, yohimbine did not increase craving for alcohol. These da
ta further implicate serotonergic systems in the discriminative proper
ties of ethanol. and may indicate a serotonergic contribution to cravi
ng. Noradrenergic systems contributed to the discriminative properties
of ethanol but not to those features of ethanol response that were sa
lient to craving in this population.